{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T09:45:25Z","timestamp":1775123125002,"version":"3.50.1"},"reference-count":57,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"am","delay-in-days":397,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","award":["R01CA259307"],"award-info":[{"award-number":["R01CA259307"]}],"id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cranio-Maxillofacial Surgery"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.jcms.2023.10.003","type":"journal-article","created":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T01:13:09Z","timestamp":1696986789000},"page":"591-596","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Current concepts in targeted therapies for benign tumors of the jaw \u2014 A review of the literature"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8271-7109","authenticated-orcid":false,"given":"Nicolas","family":"Graillon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunday O.","family":"Akintoye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4444-248X","authenticated-orcid":false,"given":"Oreste","family":"Iocca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arshad","family":"Kaleem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Souren","family":"Hajjar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5317-5889","authenticated-orcid":false,"given":"Matin","family":"Imanguli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rabie M.","family":"Shanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcms.2023.10.003_bib1","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1016\/j.joms.2020.06.016","article-title":"Positive outcomes of denosumab treatment in 2 patients with cherubism","volume":"78","author":"Bar Droma","year":"2020","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.jcms.2023.10.003_bib2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s13256-019-2140-6","article-title":"Persistent response to vemurafenib in metastatic ameloblastoma with BRAF mutation: a case report","volume":"13","author":"Broudic-Guibert","year":"2019","journal-title":"J. Med. Case Rep."},{"key":"10.1016\/j.jcms.2023.10.003_bib3","doi-asserted-by":"crossref","first-page":"5517","DOI":"10.1158\/1078-0432.CCR-14-1069","article-title":"Activating FGFR2-RAS-BRAF mutations in ameloblastoma","volume":"20","author":"Brown","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jcms.2023.10.003_bib4","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.joms.2020.01.031","article-title":"Benign pediatric jaw lesions at Massachusetts General Hospital over 13 years","volume":"78","author":"Chen","year":"2020","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.jcms.2023.10.003_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.otsr.2022.103272","article-title":"Minimally invasive treatment of aneurysmal bone cysts: systematic literature review","author":"Cottalorda","year":"2022","journal-title":"Orthop. Traumatol. Surg. Res."},{"key":"10.1016\/j.jcms.2023.10.003_bib6","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.joms.2022.03.003","article-title":"Surgical treatment of ameloblastoma: how does it impact the oral health-related quality of life? A Systematic Review","volume":"80","author":"de Campos","year":"2022","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.jcms.2023.10.003_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2022.100417","article-title":"Giant cell tumor of bone: a single center study of 115 cases","volume":"33","author":"Deventer","year":"2022","journal-title":"J. Bone Oncol."},{"key":"10.1016\/j.jcms.2023.10.003_bib8","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/odi.12646","article-title":"Ameloblastoma: current etiopathological concepts and management","volume":"24","author":"Effiom","year":"2018","journal-title":"Oral Dis."},{"key":"10.1016\/j.jcms.2023.10.003_bib9","first-page":"253","article-title":"Prompt clinical and biochemical response to denosumab in a young adult patient with craniofacial fibrous dysplasia","volume":"13","author":"Eller-Vainicher","year":"2016","journal-title":"Clin. Cases Miner Bone Metab."},{"key":"10.1016\/j.jcms.2023.10.003_bib10","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s12957-018-1478-3","article-title":"Assessment of denosumab treatment effects and imaging response in patients with giant cell tumor of bone","volume":"16","author":"Engellau","year":"2018","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.jcms.2023.10.003_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-246264","article-title":"Partial response to dabrafenib and trametinib in relapsed BRAF V600E-mutated multiple myeloma and possible mechanisms of resistance","volume":"15","author":"Ernst","year":"2022","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.jcms.2023.10.003_bib12","doi-asserted-by":"crossref","first-page":"djw190","DOI":"10.1093\/jnci\/djw190","article-title":"Durable treatment of ameloblastoma with single agent BRAFi Re: clinical and radiographic response with combined BRAF-targeted therapy in stage 4 ameloblastoma","volume":"109","author":"Faden","year":"2017","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jcms.2023.10.003_bib13","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1186\/s12885-018-4802-y","article-title":"Clinical benefit and radiological response with BRAF inhibitor in a patient with recurrent ameloblastoma harboring V600E mutation","volume":"18","author":"Fernandes","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jcms.2023.10.003_bib14","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3389\/fped.2020.00515","article-title":"Case report: safety and efficacy of denosumab in four children with Noonan syndrome with multiple giant cell lesions of the jaw","volume":"8","author":"Ferriero","year":"2020","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.jcms.2023.10.003_bib15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/1752-1947-7-223","article-title":"The CARE guidelines: consensus-based clinical case reporting guideline development","volume":"7","author":"Gagnier","year":"2013","journal-title":"J. Med. Case Rep."},{"key":"10.1016\/j.jcms.2023.10.003_bib16","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.bjoms.2019.05.023","article-title":"Management of an aggressive giant cell granuloma of the mandible with denosumab: a case report","volume":"57","author":"Hameed","year":"2019","journal-title":"Br. J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.jcms.2023.10.003_bib17","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/term.3254","article-title":"Upfront rational therapy in BRAF V600E mutated pediatric ameloblastoma promotes ad integrum mandibular regeneration","volume":"15","author":"Hirschhorn","year":"2021","journal-title":"J. Tissue Eng. Regen Med."},{"key":"10.1016\/j.jcms.2023.10.003_bib18","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/term.3254","article-title":"Upfront rational therapy in BRAF V600E mutated pediatric ameloblastoma promotes ad integrum mandibular regeneration","volume":"15","author":"Hirschhorn","year":"2021","journal-title":"J. Tissue Eng. Regen Med."},{"key":"10.1016\/j.jcms.2023.10.003_bib19","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.eprac.2022.07.012","article-title":"Denosumab use in adults with fibrous dysplasia: case reports and review of the literature","volume":"28","author":"Hung","year":"2022","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.jcms.2023.10.003_bib20","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1515\/jpem-2019-0581","article-title":"Efficacy and safety of denosumab treatment in a prepubertal patient with cherubism","volume":"33","author":"Kawamura","year":"2020","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.jcms.2023.10.003_bib21","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/jnci\/dju378","article-title":"Clinical and radiographic response with combined BRAF-targeted therapy in stage 4 ameloblastoma","volume":"107","author":"Kaye","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jcms.2023.10.003_bib22","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13073","article-title":"Activation of Wnt signalling reduces the population of cancer stem cells in ameloblastoma","volume":"54","author":"Kim","year":"2021","journal-title":"Cell Prolif."},{"key":"10.1016\/j.jcms.2023.10.003_bib23","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/j.joms.2014.05.027","article-title":"Odontogenic myxoma of the face: mimicry of cherubism","volume":"72","author":"Kleiber","year":"2014","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.jcms.2023.10.003_bib24","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/path.4317","article-title":"High frequency of BRAF V600E mutations in ameloblastoma","volume":"232","author":"Kurppa","year":"2014","journal-title":"J. Pathol."},{"key":"10.1016\/j.jcms.2023.10.003_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26926","article-title":"Denosumab treatment in aneurysmal bone cyst: evaluation of nine cases","volume":"65","author":"Kurucu","year":"2018","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.jcms.2023.10.003_bib26","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1471-2350-7-84","article-title":"A novel mutation in the SH3BP2 gene causes cherubism: case report","volume":"7","author":"Li","year":"2006","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.jcms.2023.10.003_bib27","doi-asserted-by":"crossref","first-page":"e267","DOI":"10.1097\/SCS.0000000000007112","article-title":"Pediatric mandibular central giant cell granuloma: neoadjuvant immunotherapy to minimize surgical resection","volume":"32","author":"Lin","year":"2021","journal-title":"J. Craniofac. Surg."},{"key":"10.1016\/j.jcms.2023.10.003_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2021.116301","article-title":"RANKL inhibition halts lesion progression and promotes bone remineralization in mice with fibrous dysplasia","volume":"156","author":"Liu","year":"2022","journal-title":"Bone"},{"key":"10.1016\/j.jcms.2023.10.003_bib29","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/scd.12588","article-title":"Successful denosumab treatment for central giant cell granuloma in a 9-year-old child","volume":"41","author":"Mariz","year":"2021","journal-title":"Spec. Care Dent."},{"key":"10.1016\/j.jcms.2023.10.003_bib30","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1051\/sicotj\/2017041","article-title":"Giant cell tumor of bone revisited","volume":"3","author":"Mavrogenis","year":"2017","journal-title":"SICOT J"},{"key":"10.1016\/j.jcms.2023.10.003_bib31","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jcms.2023.10.003_bib32","series-title":"The Joanna Briggs Institute","article-title":"Joanna Briggs Institute reviewer's manual. Chapter 7: systematic reviews of etiology and risk","author":"Moola","year":"2017"},{"key":"10.1016\/j.jcms.2023.10.003_bib33","doi-asserted-by":"crossref","first-page":"e4079","DOI":"10.1097\/GOX.0000000000004079","article-title":"Severe cherubism treated with curettage, osteotomy, and bony repositioning: a case series of three patients","volume":"10","author":"Moss","year":"2022","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"10.1016\/j.jcms.2023.10.003_bib34","first-page":"2127","article-title":"Methodological quality of case series studies: an introduction to the JBI critical appraisal tool","volume":"18","author":"Munn","year":"2020","journal-title":"JBI Evid. Synth."},{"key":"10.1016\/j.jcms.2023.10.003_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.708380","article-title":"A protocol for the use of case reports\/studies and case series in systematic reviews for clinical toxicology","volume":"8","author":"Nambiema","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.jcms.2023.10.003_bib36","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/1756-0500-7-264","article-title":"The clinical case report: a review of its merits and limitations","volume":"7","author":"Nissen","year":"2014","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.jcms.2023.10.003_bib37","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/jop.13108","article-title":"Discrepancy between immunohistochemistry and sequencing for BRAF V600E in odontogenic tumours: comparative analysis of two VE1 antibodies","volume":"50","author":"Oh","year":"2021","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.jcms.2023.10.003_bib38","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13643-018-0699-4","article-title":"Registration of systematic reviews in PROSPERO: 30,000 records and counting","volume":"7","author":"Page","year":"2018","journal-title":"Syst. Rev."},{"key":"10.1016\/j.jcms.2023.10.003_bib39","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jcms.2023.10.003_bib40","article-title":"Differential profile of primary and recurrent ameloblastomas among Afro-descendants and non-Afro-descendants \u2014 a systematic review","author":"Patel","year":"2023","journal-title":"J. Racial Ethn Health Disparities"},{"key":"10.1016\/j.jcms.2023.10.003_bib41","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.ijom.2020.12.013","article-title":"Denosumab for the management of central giant cell granuloma of the jaws-a case series","volume":"50","author":"Pogrel","year":"2021","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.jcms.2023.10.003_bib42","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1007\/s00198-021-05895-6","article-title":"Denosumab for craniofacial fibrous dysplasia: duration of efficacy and post-treatment effects","volume":"32","author":"Raborn","year":"2021","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.jcms.2023.10.003_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.joms.2019.02.021","article-title":"A paradigm shift in the management of cherubism? A preliminary report using imatinib","volume":"77","author":"Ricalde","year":"2019","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.jcms.2023.10.003_bib44","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jclinepi.2017.04.026","article-title":"CARE guidelines for case reports: explanation and elaboration document","volume":"89","author":"Riley","year":"2017","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.jcms.2023.10.003_bib45","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1111\/bcp.13820","article-title":"Clinical and translational pharmacological aspects of the management of fibrous dysplasia of bone","volume":"85","author":"Rotman","year":"2019","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jcms.2023.10.003_bib46","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.joms.2014.02.017","article-title":"Alternative pharmacologic therapy for aggressive central giant cell granuloma: denosumab","volume":"72","author":"Schreuder","year":"2014","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.jcms.2023.10.003_bib47","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ejca.2022.08.011","article-title":"RANKL inhibition for giant cell lesions of the jaw: a retrospective cohort analysis","volume":"175","author":"Schreuder","year":"2022","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jcms.2023.10.003_bib48","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.surge.2020.06.009","article-title":"Ameloblastoma: a succinct review of the classification, genetic understanding and novel molecular targeted therapies","volume":"19","author":"Shi","year":"2021","journal-title":"Surgeon"},{"key":"10.1016\/j.jcms.2023.10.003_bib49","first-page":"168","article-title":"The World health organization classification of odontogenic lesions: a summary of the changes of the 2022 (5th) edition","volume":"38","author":"Soluk-Tekkesin","year":"2022","journal-title":"Turk. Patoloji Derg."},{"key":"10.1016\/j.jcms.2023.10.003_bib50","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ng.2986","article-title":"Identification of recurrent SMO and BRAF mutations in ameloblastomas","volume":"46","author":"Sweeney","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jcms.2023.10.003_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.oooo.2015.12.016","article-title":"BRAF inhibitor treatment of primary BRAF-mutant ameloblastoma with pathologic assessment of response","volume":"122","author":"Tan","year":"2016","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"10.1016\/j.jcms.2023.10.003_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2022.116395","article-title":"Denosumab for central giant cell granuloma in an Australian tertiary paediatric centre","volume":"159","author":"Vanderniet","year":"2022","journal-title":"Bone"},{"key":"10.1016\/j.jcms.2023.10.003_bib53","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s12105-017-0794-1","article-title":"Update from the 4th edition of the World health organization classification of head and neck tumours: odontogenic and maxillofacial bone tumors","volume":"11","author":"Wright","year":"2017","journal-title":"Head Neck Pathol."},{"key":"10.1016\/j.jcms.2023.10.003_bib54","doi-asserted-by":"crossref","first-page":"5758","DOI":"10.3390\/cancers14235758","article-title":"Progress on denosumab use in giant cell tumor of bone: dose and duration of therapy","volume":"14","author":"Xiang","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.jcms.2023.10.003_bib55","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s00223-021-00935-z","article-title":"Clinical and radiologic response of central giant cell granuloma to denosumab: a 6-year prospective observational study","volume":"110","author":"YJJ","year":"2022","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.jcms.2023.10.003_bib56","doi-asserted-by":"crossref","first-page":"323","DOI":"10.4103\/ijdr.ijdr_456_22","article-title":"Effectiveness of molecular-targeted chemotherapy in ameloblastomas: a systematic review","volume":"33","author":"Yoithapprabhunath","year":"2022","journal-title":"Indian J. Dent. Res."},{"key":"10.1016\/j.jcms.2023.10.003_bib57","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41368-018-0034-x","article-title":"Effect of the sonic hedgehog inhibitor GDC-0449 on an in vitro isogenic cellular model simulating odontogenic keratocysts","volume":"11","author":"Zhai","year":"2019","journal-title":"Int. J. Oral Sci."}],"container-title":["Journal of Cranio-Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1010518223001932?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1010518223001932?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T14:46:06Z","timestamp":1760885166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1010518223001932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":57,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S1010518223001932"],"URL":"https:\/\/doi.org\/10.1016\/j.jcms.2023.10.003","relation":{},"ISSN":["1010-5182"],"issn-type":[{"value":"1010-5182","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current concepts in targeted therapies for benign tumors of the jaw \u2014 A review of the literature","name":"articletitle","label":"Article Title"},{"value":"Journal of Cranio-Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcms.2023.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}